Same-day HIV prevention shot study
Part of Infections clinical trials.
This study tests if starting a new HIV prevention shot (lenacapavir) on the same day you see a doctor and having a say in your follow-up care can help people stick with their prevention routine. It may be an option for you if you are looking for a long-acting HIV prevention method.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You do not have HIV (must test negative).
- A doctor has said you are eligible for HIV prevention medication (PrEP).
- You are willing to receive the injectable study drug lenacapavir and follow the study plan.
- You live in Massachusetts and can commit to a 6-month follow-up.
- You are not currently pregnant (if you become pregnant during the study, you may choose to stay enrolled).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers a long-acting injectable form of PrEP (lenacapavir) to prevent HIV in Latine transgender women and gay men in the South. It aims to make HIV prevention easier by providing a shot instead of a daily pill.
This study tests if giving a long-acting HIV prevention shot (lenacapavir) from a mobile medical van can reach people at risk for HIV in Los Angeles County. You may be able to join if you are HIV negative, at risk for HIV, and are willing to try a shot instead of a daily pill.
This trial tests a new HIV prevention medicine called lenacapavir, given as a shot every six months. It's for young people at risk of HIV who haven't used PrEP before or have had gaps in their PrEP use.
This trial tests a new medication, lenacapavir, to see how well it works for preventing HIV. It is for people who want or need PrEP (a medicine to prevent HIV) and are interested in learning about different options.
This study offers a new injectable medication called lenacapavir to prevent HIV. It is for people who are HIV-negative and sexually active, and want to try a long-acting injection instead of daily pills.
This trial tests a nurse-run program that makes it easier to get long-acting injectable PrEP (cabotegravir) for HIV prevention. It aims to see if nurses can start and provide this shot quickly at your regular clinic visits.
Hear when a new HIV Pre-exposure Prophylaxis Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.